
1. gene ther. 2012 jul;19(7):742-51. doi: 10.1038/gt.2011.116. epub 2011 sep 8.

toxicity exposure adenovirus containing human interferon alpha-2b
following intracystic administration cynomolgus monkeys.

veneziale rw(1), kishnani ns, nelson j, resendez jc, frank dw, cai xy, xie l,
cullen c, frugone ca, rosenfeld c, hubbell j, maxwell se, sugarman bj, hutchins
b, maneval d, treinen ka.

author information: 
(1)pfizer inc., pearl river, ny, usa. robert.veneziale@pfizer.com

the safety toxicokinetics sch 721015, adenovirus encoding human
interferon alpha-2b gene, syn3 (sch 209702), novel excipient, assessed
in cynomolgus monkeys administered intravesical doses 2.5 × 10e11 1.25 ×
10e13 particles sch 721015 25 mg syn3 25 mg syn3 alone study days 1 
91. systemic toxicity. monkeys dosed sch 721015 syn3 were
positive sch 721015-specific dna urine 2 3 days following 
dose interferon alpha-2b protein urine 1-3 days single
dose fewer animals second dose. intracystic administration was
associated inflammation focal/multifocal ulceration urinary
bladder irritation ureters urethra necropsy. physical
trauma catheterization filling/emptying bladder likely a
contributing factor syn3 exacerbated trauma. nearly complete
resolution findings 2 months last dose. trauma the
bladder likely contributed low, transient systemic exposure syn3, sch
721015 human interferon protein. results study support the
clinical investigation sch 721015 syn3.

doi: 10.1038/gt.2011.116 
pmid: 21900961  [indexed medline]

